Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Moxifloxacin (0.5% w/v) + Dexamethasone (0.1% w/v)
Therapeutic Category
Ophthalmology, Antibiotic
Dosage Form
Eye Drops
Packaging Type
vial
Packaging
mono
Price
₹130/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Moxolunic D Eye Drops is a WHO-GMP certified otic formulation containing Moxifloxacin 0.5% w/v and Dexamethasone 0.1% w/v, developed to manage bacterial ear infections with associated inflammation.
Moxifloxacin, a fourth-generation fluoroquinolone antibiotic, targets a broad spectrum of Gram-positive and Gram-negative bacteria by inhibiting DNA gyrase, essential for bacterial replication. Dexamethasone, a potent corticosteroid, helps relieve inflammation, swelling, and discomfort in the Eye.
This combination is especially beneficial in treating conditions like otitis externa and post-surgical Eye infections, offering both antibacterial action and symptomatic relief. It is recommended to be used under the guidance of a healthcare professional to avoid resistance and ensure effective therapy.
Possible side effects include: Burning or stinging sensation in the ear Ear irritation or itching Rare allergic reactions like rash or swelling Temporary dizziness or discomfort If any severe reactions occur, such as severe pain or allergic reactions, discontinue use and seek immediate medical advice.
Moxolunic D Ear Drop is indicated for the treatment of: Otitis externa (outer ear canal infection) Otitis media (middle ear infection) Inflammation caused by ear infections
Consult a doctor before use if you have a history of ear problems, are pregnant, or breastfeeding.
Store in a cool, dry place, away from direct sunlight. Do not freeze. Keep out of reach of children.
Composition : Ofloxacin (0.3% w/v) + Ketorolac (0.5% w/v)
Composition : Ketorolac (5% w/v) + Moxifloxacin (0.5% w/v)
Composition : Moxifloxacin (0.5% w/v) + Prednisolone (1% w/v)
Composition : Moxifloxacin (0.5% w/v) + Difluprednate (0.05% w/v)
Composition : Moxifloxacin (5% w/v) + Betamethasone (0.1% w/v)
Composition : Ofloxacin (0.3% w/v) Eye Ear Drops
Composition : Flurbiprofen (0.03% w/v) + Gatifloxacin (0.3% w/v)
Composition : Gatifloxacin (0.3% w/v)
Composition : Moxifloxacin (0.5% w/v)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Moxifloxacin 0.5% w/v + Dexamethasone 0.1% w/v Ear Drops have strong demand in the ENT, anti-infective, and specialty healthcare segment, making them a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on ear care and infection management portfolios.
Medical distributors and agencies can benefit from consistent demand for ear infection and inflammation management under medical supervision. Moxifloxacin 0.5% w/v is a broad-spectrum fluoroquinolone antibiotic that helps control susceptible bacterial infections Dexamethasone 0.1% w/v is a corticosteroid that helps reduce inflammation, redness, swelling, irritation, and discomfort Commonly prescribed for bacterial ear infections, otitis externa, inflammatory ear conditions, and post-procedural ear care as advised by healthcare professionals The combination helps manage both infection and associated inflammation simultaneously Ear drop formulation provides targeted delivery directly to the affected ear Widely prescribed by ENT specialists, physicians, and healthcare professionals This strengthens a comprehensive ENT and anti-infective portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Moxifloxacin 0.5% w/v + Dexamethasone 0.1% w/v Ear Drops with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from steady ENT prescription demand, repeat orders, reliable supply chain support, and attractive margins in the specialty ear care and anti-infective segment.
Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality product ranges, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.